drugset / Trial / NCT00691405
A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupDouble-blindTreatment
Summary
A dose ranging study to evaluate the safety, tolerability and efficacy of arformoterol (given once or twice a day) in subjects with COPD.
Timeline
- Start
- 2003-10
- Primary completion
- 2004-05
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Arformoterol | Small molecule | 5 ug | Inhaled |
| Subject | Arformoterol | Small molecule | 15 ug | Inhaled |
| Subject | Arformoterol | Small molecule | 25 ug | Inhaled |
| Subject | Arformoterol | Small molecule | 50 ug | Inhaled |